City

Guangzhou (2)

Shanghai (2)

Suzhou (2)

Changsha (1)

Tianjin (1)

Zhengzhou (1)

Condition

Clinical High Risk Syndrome of Psychosis (2)

Overall Status

Recruiting (2)

Sign in for free

Phase

n/a (1)

phase 3 (1)

Sponsor

Shanghai Jiao Tong University School of Medicine (2)

Collaborator

Guangzhou Psychiatric Hospital (2)

Suzhou Psychiatric Hospital (2)

Second Xiangya Hospital of Central South University (1)

Shanghai Pudong Nanhui Mental Health Center (1)

Shanghai Xuhui District Mental Health Center (1)

Shenzhen Fushan Biotech Co., Ltd. (1)

The First Affiliated Hospital of Zhengzhou University (1)

Tianjin Anding Hospital (1)

Intervention

placebo (1)

repetitive transcranial magnetic stimulation (rtms) (1)

sulforaphane (1)

Study Documents

Intervention Type

combination product (1)

device (1)

dietary supplement (1)

Funder Type

Other (2)

Study Type

Interventional (2)

clinical high risk syndrome of psychosis

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Clinical High Risk Syndrome of Psychosis Trial in China (Sulforaphane, Placebo)

Recruiting

Clinical High Risk Syndrome of Psychosis

Sulforaphane
Placebo

Guangzhou, Guangdong, China
+7 more

Nov 9, 2022

Clinical High Risk Syndrome of Psychosis Trial in Guangzhou, Suzhou, Shanghai (repetitive transcranial magnetic stimulation

Recruiting

Clinical High Risk Syndrome of Psychosis

repetitive transcranial magnetic stimulation (rTMS)

Guangzhou, Guangdong, China
+2 more

Apr 18, 2021